Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Long-Term Investments (2021 - 2024)

Pulmonx has reported Long-Term Investments over the past 4 years, most recently at $4.3 million for Q1 2024.

  • Quarterly Long-Term Investments rose 62.8% to $4.3 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Mar 2024, up 62.8% year-over-year, with the annual reading at $14.4 million for FY2023, 142.91% up from the prior year.
  • Long-Term Investments was $4.3 million for Q1 2024 at Pulmonx, down from $14.4 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $23.3 million in Q3 2023 and troughed at $2.0 million in Q2 2021.
  • The 4-year median for Long-Term Investments is $5.3 million (2022), against an average of $7.7 million.
  • The largest YoY upside for Long-Term Investments was 165.88% in 2023 against a maximum downside of 58.66% in 2023.
  • A 4-year view of Long-Term Investments shows it stood at $10.9 million in 2021, then crashed by 45.86% to $5.9 million in 2022, then skyrocketed by 142.91% to $14.4 million in 2023, then plummeted by 70.17% to $4.3 million in 2024.
  • Per Business Quant, the three most recent readings for LUNG's Long-Term Investments are $4.3 million (Q1 2024), $14.4 million (Q4 2023), and $23.3 million (Q3 2023).